Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14563254 | 1.00 | CYP3A4 (0.38) | CYP3A4CYP2C9KCNH2NR1I2ABCB11 | |
| SCHEMBL19458449 | 1.00 | CYP3A4 (0.38) | CYP3A4CYP2C9KCNH2NR1I2ABCB11 | |
| SCHEMBL14563253 | 1.00 | CYP3A4 (0.38) | CYP3A4CYP2C9KCNH2NR1I2ABCB11 | |
| SCHEMBL3052020 | 0.92 | CYP3A4 (0.35) | CYP3A4CYP2C9KCNH2NR1I2ABCB11 | |
| SCHEMBL3052013 | 0.92 | CYP3A4 (0.35) | CYP3A4CYP2C9KCNH2NR1I2ABCB11 | |
| SCHEMBL10201514 | 0.92 | CYP3A4 (0.39) | CYP3A4CYP2C9KCNH2 | |
| SCHEMBL12373803 | 0.92 | CYP3A4 (0.39) | CYP3A4CYP2C9KCNH2 | |
| SCHEMBL16223503 | 0.92 | CYP3A4 (0.40) | CYP3A4CYP2C9KCNH2NR1I2ABCB11 | |
| SCHEMBL16223458 | 0.92 | CYP3A4 (0.40) | CYP3A4CYP2C9KCNH2NR1I2ABCB11 | |
| SCHEMBL16223456 | 0.92 | CYP3A4 (0.40) | CYP3A4CYP2C9KCNH2NR1I2ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2601188-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-10-18 | — | — | EP | disclosed |